Tissue engineered biomaterials have the potential to regenerate almost every tissue type. One difficult aspect to advancing this technology is determining the properties and fate of these materials once introduced in vivo. Non-invasive imaging technology such as MRI holds significant potential for monitoring implanted biomaterials. Few novel approaches to directly image biomaterials have recently been developed; however, most are designed for specific materials or utilize iron oxides with limited specificity. In this study, we investigate a novel approach to labelling biomaterials with a highly efficient T1 agent and a biologically derived adhesive, which allows for accurate and sensitive detection in vivo.
This abstract and the presentation materials are available to members only; a login is required.